These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21092635)

  • 1. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
    Lu Y; Wang B; Zhao WJ; Zheng MQ; Li P; Fu L; Liang BW
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo].
    Lu Y; Zheng MQ; Wang B; Zhao WJ; Li P; Chu NH; Liang BW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):752-5. PubMed ID: 19080601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of
    Lanoix JP; Joseph C; Peltier F; Castelain S; Andréjak C
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activities of clofazimine with moxifloxacin or capreomycin against Mycobacterium tuberculosis in China.
    Li G; Xu Z; Jiang Y; Liu H; Zhao LL; Li M; Xu D; Zhao X; Liu Z; Wang R; Wan K
    Int J Antimicrob Agents; 2019 Nov; 54(5):642-646. PubMed ID: 31200023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.
    Zhang Z; Li T; Qu G; Pang Y; Zhao Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters.
    Xu J; Lu Y; Fu L; Zhu H; Wang B; Mdluli K; Upton AM; Jin H; Zheng M; Zhao W; Li P
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1119-25. PubMed ID: 22691726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activities of clofazimine against different drug-resistant types of Mycobacterium tuberculosis].
    Gui XW; Xiao HP; Hu ZY; Cui ZL; Wang J; Lu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Aug; 34(8):579-81. PubMed ID: 22168978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multicenter, randomized controlled study in China.
    Tang S; Yao L; Hao X; Liu Y; Zeng L; Liu G; Li M; Li F; Wu M; Zhu Y; Sun H; Gu J; Wang X; Zhang Z
    Clin Infect Dis; 2015 May; 60(9):1361-7. PubMed ID: 25605283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of less lipophilic riminophenazine derivatives for the treatment of drug-resistant tuberculosis.
    Zhang D; Lu Y; Liu K; Liu B; Wang J; Zhang G; Zhang H; Liu Y; Wang B; Zheng M; Fu L; Hou Y; Gong N; Lv Y; Li C; Cooper CB; Upton AM; Yin D; Ma Z; Huang H
    J Med Chem; 2012 Oct; 55(19):8409-17. PubMed ID: 22931472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease.
    Converse PJ; Tyagi S; Xing Y; Li SY; Kishi Y; Adamson J; Nuermberger EL; Grosset JH
    PLoS Negl Trop Dis; 2015; 9(6):e0003823. PubMed ID: 26042792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    Byrne ST; Denkin SM; Zhang Y
    J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study on the activities of six combination regimens against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.
    Zheng M; Jin H; Fu L; Xu J; Wang B; Zhao W; Zhu H; Li P; Lu Y; Li Q
    J Chemother; 2013 Apr; 25(2):81-6. PubMed ID: 23684355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
    Dutta NK; Mazumdar K; Dastidar SG; Park JH
    Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic efficacy of kanamycin and clofazimine combined with muramyl dipeptide against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Dec; 66(12):811-7. PubMed ID: 1784098
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Xu J; Wang B; Fu L; Zhu H; Guo S; Huang H; Yin D; Zhang Y; Lu Y
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofazimine in the treatment of multidrug-resistant tuberculosis.
    Xu HB; Jiang RH; Xiao HP
    Clin Microbiol Infect; 2012 Nov; 18(11):1104-10. PubMed ID: 22192631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.
    López-Gavín A; Tudó G; Vergara A; Hurtado JC; Gonzalez-Martín J
    Int J Antimicrob Agents; 2015 Nov; 46(5):582-5. PubMed ID: 26421981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.